Optique 1
- Manufacturer
- Laboratoires Boiron | Boiron Inc. | Boiron
- Effective date
- 2023-01-06
- Label type
- HUMAN OTC DRUG LABEL
- Version
- 10
- Source
- legacy-cache
- Hydrated at
- 2026-08-01 21:41:21
Label at a glance#
Contacts and useful links#
Label contents#
Full prescribing information#
OTC - ACTIVE INGREDIENT SECTION
Active ingredients**
Calcarea fluorica 10X HPUS 0.25%
Calendula officinalis 4X HPUS 0.25%
Cineraria maritima 6C HPUS 1.50% (contains less than 10 -13 mg pyrrolizidine alkaloids)
Euphrasia officinalis 4X HPUS 1.00%
Kali Muriaticum 10X HPUS 0.25%
Magnesia carbonica 10X HPUS 0.25%
Silicea 10X HPUS 0.25%
The letters "HPUS" indicate that the component in this product is officially monographed in Homeopathic Pharmacopoeia of the United States.
OTC - PURPOSE SECTION
Purpose*
Calcarea fluorica 10X HPUS 0.25% ... Relieves eyestrain and fatigue characterized by flickering light
Calendula officinalis 4X HPUS 0.25% ... Relieves eye dryness associated with smoke or airborne irritants
Cineraria maritima 6C HPUS 1.50% (contains less than 10-13 mg pyrrolizidine alkaloids) ... Soothes sensitivity to light and glare
Euphrasia officinalis 4X HPUS 1.00% ...Relieves burning, irritated eyes
Kali Muriaticum 10X HPUS 0.25% ... Alleviates gritty sensation (feeling of sand in the eye)
Magnesia carbonica 10X HPUS 0.25% ... Relieves sharp and brief eye irritation associated with eye fatigue
Silicea 10X HPUS 0.25% ... Relieves tired eyes
INDICATIONS & USAGE SECTION
Uses*
temporarily relieves minor irritation such as dry, red, itchy, and burning eyes due to:
- eyestrain and fatigue
- light and glare
- digital displays
- airborne irritants (pollens and dust)
WARNINGS SECTION
Warnings
Obtain immediate medical treatment for all open wounds in or near the eyes.
To avoid contamination
- do not touch tip of dropper to any surface
- do not touch the eye with the tip of the dropper
- do not reuse
- once opened, discard dropper after each use.
OTC - DO NOT USE SECTION
Do not use if solution changes color or become cloudy.
OTC - STOP USE SECTION
Stop use and ask doctor if you experience eye pain, changes in vision, continued redness or irritation of the eye, or if the condition worsens or persists for more than 72 hours.
OTC - PREGNANCY OR BREAST FEEDING SECTION
If pregnant or breastfeeding, ask a health professional before use.
OTC - KEEP OUT OF REACH OF CHILDREN SECTION
Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.
DOSAGE & ADMINISTRATION SECTION
Directions
Adults and children 2 years of age and older: At the onset of symptoms, put 1 to 2 drops, or more if necessary, in affected eye(s).
Repeat 2 to 6 times a day, as needed, or as directed by a doctor.
Children under 2 years of age: Ask a doctor.
INACTIVE INGREDIENT SECTION
alcohol, purified water, sodium chloride
OTC - QUESTIONS SECTION
Questions or comments?
Boironusa.com
Info@boironusa.com
1-800-BOIRON-1 (1-800-264-7661)
Distributed by Boiron, Inc. Newtown Square, PA 19073
SPL UNCLASSIFIED SECTION
Other information
do not use if glued carton end flaps are open or if inner foil pouch and droppers are not intact
do not refrigerate or freeze
after opening foil pouch: store unused droppers in the foul pouch for no longer 3 months at a temperature that does not exceed 77 ° (25°)
after opening the dropper: the product must be used immediately
after administering discard dropper
do not reuse
contains 0.00916% alcohol
isotonic to tears
1. Tear open the foil pouch at the notched edge. 2. Snap off one single-use dropper. 3. Twist open. 4. Put 1 to 2 drops, or more if necessary in affected eye(s).
Sterile Single-Use Dropper
Soothing & Refreshing
Preservative-Free
Eye Irritation Relief*
Dry Eyes, Allergies, Eyestrain
Soothing & Refreshing
Preservative-Free
30 Sterile Single-Use Droppers
.013 fl oz
(.4 mL) per dropper
No-Sting Formula
No Vasoconstrictors or Astringents
No Rebound Redness
No Preservatives
* CLAIMS BASED ON TRADITIONAL HOMEOPATHIC PRACTICE, NOT ACCEPTED MEDICAL EVIDENCE. NOT FDA EVAULATED.
** C, K, CK and X are homeopathic dilutions: see BoironUSA.com/info for details.
PACKAGE LABEL.PRINCIPAL DISPLAY PANEL
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 0220-9277-71 | 2020-02-26 | C162847 | 48780-1 | 9d75b9d0-9b11-f424-e053-dadaa90a57ce | Optique 1 |
| 0220-9277-72 | 2020-02-26 | C162847 | 48780-1 | 9d75b9d0-9b11-f424-e053-dadaa90a57ce | Optique 1 |
| 0220-9277-76 | 2020-02-26 | C162847 | 48780-1 | 9d75b9d0-9b11-f424-e053-dadaa90a57ce | Optique 1 |
| 0220-9277-71 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-9b11-f424-e053-dadaa90a57ce | Optique 1 |
| 0220-9277-72 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-9b11-f424-e053-dadaa90a57ce | Optique 1 |
| 0220-9277-76 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-9b11-f424-e053-dadaa90a57ce | Optique 1 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| CALCIUM FLUORIDE | ACTIVE INGREDIENT | O3B55K4YKI | 4 | |
| CALENDULA OFFICINALIS FLOWERING TOP | ACTIVE INGREDIENT | 18E7415PXQ | 4 | |
| EUPHRASIA STRICTA | ACTIVE INGREDIENT | C9642I91WL | 4 | |
| JACOBAEA MARITIMA | ACTIVE INGREDIENT | U4B223LS4X | 4 | |
| MAGNESIUM CARBONATE | ACTIVE INGREDIENT | 0E53J927NA | 4 | |
| POTASSIUM CHLORIDE | ACTIVE INGREDIENT | 660YQ98I10 | 4 | |
| SILICON DIOXIDE | ACTIVE INGREDIENT | ETJ7Z6XBU4 | 4 | |
| CALENDULA OFFICINALIS FLOWERING TOP | ACTIVE MOIETY | 18E7415PXQ | 4 | |
| CARBONATE ION | ACTIVE MOIETY | 7UJQ5OPE7D | 4 | |
| EUPHRASIA STRICTA | ACTIVE MOIETY | C9642I91WL | 4 | |
| FLUORIDE ION | ACTIVE MOIETY | Q80VPU408O | 4 | |
| JACOBAEA MARITIMA | ACTIVE MOIETY | U4B223LS4X | 4 | |
| POTASSIUM CATION | ACTIVE MOIETY | 295O53K152 | 4 | |
| SILICON DIOXIDE | ACTIVE MOIETY | ETJ7Z6XBU4 | 4 | |
| SODIUM CHLORIDE | INACTIVE INGREDIENT | 451W47IQ8X | 4 | |
| WATER | INACTIVE INGREDIENT | 059QF0KO0R | 4 |
Products#
Every source-derived product name is available through these pages.
- Optique 1
- JACOBAEA MARITIMA, EUPHRASIA STRICTA, CALENDULA OFFICINALIS FLOWERING TOP, POTASSIUM CHLORIDE, SILICON DIOXIDE, CALCIUM FLUORIDE, MAGNESIUM CARBONATE
- WATER
- SODIUM CHLORIDE
- JACOBAEA MARITIMA
- EUPHRASIA STRICTA
- CALENDULA OFFICINALIS FLOWERING TOP
- POTASSIUM CHLORIDE
- POTASSIUM CATION
- SILICON DIOXIDE
- CALCIUM FLUORIDE
- FLUORIDE ION
- MAGNESIUM CARBONATE
- CARBONATE ION
- ALCOHOL
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 0220-9277 | 0220-9277-76, 0220-9277-71, 0220-9277-72 |
Ingredients#
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| WATER | 059QF0KO0R | IACT |
| SODIUM CHLORIDE | 451W47IQ8X | IACT |
| JACOBAEA MARITIMA | U4B223LS4X | ACTIB |
| EUPHRASIA STRICTA | C9642I91WL | ACTIB |
| CALENDULA OFFICINALIS FLOWERING TOP | 18E7415PXQ | ACTIB |
| POTASSIUM CHLORIDE | 660YQ98I10 | ACTIB |
| SILICON DIOXIDE | ETJ7Z6XBU4 | ACTIB |
| CALCIUM FLUORIDE | O3B55K4YKI | ACTIM |
| MAGNESIUM CARBONATE | 0E53J927NA | ACTIB |
| ALCOHOL | 3K9958V90M | IACT |
Source Document#
Inactive ingredient matches#
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | INJECTION / INTRATHECAL | 9 mg | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | INJECTION, SUSPENSION, EXTENDED RELEASE / INTRAMUSCULAR | 24 mg | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | DROPS / ORAL | NA | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | INJECTION, SOLUTION / SUBARACHNOID | 0.9 %w/v | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | INJECTION / PARENTERAL | 584 mg | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | GRANULE, FOR SUSPENSION / ORAL | 162 mg | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | TABLET, CHEWABLE / ORAL | 20 mg | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | ELIXIR / ORAL | 1 mg | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | DROPS / OPHTHALMIC | 0.08 %w/w | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | TABLET, DELAYED RELEASE / ORAL | 97 mg | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | INJECTION / INTRADERMAL | 7 mg | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | GEL / OPHTHALMIC | 0.9 %w/v | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | ENEMA / RECTAL | 0.7 %w/w | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | SOLUTION/ DROPS / TOPICAL | 0.86 %w/v | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | INJECTION, SOLUTION / INTRATHECAL | 131 mg | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | SUPPOSITORY / RECTAL | 140 mg | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | INJECTION / INTRACARDIAC | 70 mg | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | INJECTION, POWDER, FOR SOLUTION / INTRA-ARTERIAL | 1.35 mg | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | LIQUID / NASAL | 7.4 mg/1ml | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | INJECTION / INTRAVITREAL | 10 %w/v | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | SPRAY, METERED / NASAL | 36 mg | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | INJECTION / INTRA-ARTICULAR | 26 mg | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | SOLUTION / OPHTHALMIC | 13 mg | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | SOAP / TOPICAL | 1.26 %w/w | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | SOLUTION / RESPIRATORY (INHALATION) | 108 mg | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | SUSPENSION / INTRATYMPANIC | 2 mg | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | IMPLANT / SUBCUTANEOUS | 77 mg | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | SUSPENSION / AURICULAR (OTIC) | 0.9 %w/v | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | SHAMPOO / TOPICAL | 150 mg | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | SUSPENSION/ DROPS / TOPICAL | 0.23 %w/v | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | INJECTION / PERINEURAL | 648 mg | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | INJECTION / INTRABURSAL | 9 mg | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | LOTION / TOPICAL | 0.3 %w/v | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | INJECTION, SUSPENSION / INTRAMUSCULAR | 26 mg | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | POWDER, FOR SUSPENSION / ENDOTRACHEAL | 46.76 mg | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | INJECTION / INTRAVASCULAR | 0.86 %w/v | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | INJECTION / INTRATUMOR | 1.2 %w/v | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | INJECTION, SUSPENSION / SOFT TISSUE | 26 mg | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | INJECTION / SUBMUCOSAL | 17 mg | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | LIQUID / SUBCUTANEOUS | 0.7 %w/v | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRAVENOUS | 1800 mg | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | SUSPENSION/ DROPS / AURICULAR (OTIC) | 3 mg | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | SUSPENSION / ENDOTRACHEAL | 7.6 mg | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | SOLUTION / INTRAVENOUS | 90 mg | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | TABLET, EXTENDED RELEASE / ORAL | 335.1 mg | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | SOLUTION / EPIDURAL | 0.9 %w/v | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | INJECTION, SUSPENSION, LIPOSOMAL / EPIDURAL | 11 mg | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | SOLUTION / SUBCUTANEOUS | 90 mg | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | INJECTION, SUSPENSION / INTRALESIONAL | 13 mg | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | SYSTEM / TOPICAL | 3.1 mg | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | CREAM / TOPICAL | 0.4 %w/w | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | SOLUTION / AURICULAR (OTIC) | 18 mg | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | INJECTION, SOLUTION / PARENTERAL | 210 mg | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | TABLET, ORALLY DISINTEGRATING / ORAL | 10 mg | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | POWDER, DENTIFRICE / DENTAL | 0.03 mg/mg | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | INJECTION / DENTAL | 0.4 %w/v | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | POWDER / RESPIRATORY (INHALATION) | NA | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | INJECTION, SOLUTION / SUBCUTANEOUS | 1486 mg | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | INJECTION, SOLUTION, CONCENTRATE / INTRAOCULAR | 0.86 %w/v | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | TABLET / ORAL | 231 mg |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 06bcb6da-6f2d-c59b-e063-6294a90ac15d | 3a667617-e90c-406e-9a64-e2b8bff39614 | 2023-10-02 | Warnings | 3a667617-e90c-406e-9a64-e2b8bff39614 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.



